Dr. de Ceglia’s line of research has focused on aberrant food consumption models (palatable food abstinence, binge eating disorder, obesity), in which she has investigated the pathophysiological and therapeutic role of the endocannabinoid and para-cannabinoid systems, both centrally and peripherally. She has contributed to the discovery of the antisteatotic and anti-obesity effects of several molecules acting on the endocannabinoid system. She has also collaborated on research into the anti-binge effects of oleoylethanolamide and its derivatives OLHHA and OLS. At the same time, part of her research has focused on the brain-level effects of aberrant nutrition, investigating markers of neurodegeneration, neuroinflammation, neuronal survival, and neurogenesis in models of Alzheimer’s disease, obesity and binge eating, as well as perinatal exposure models. With the award of the Sara Borrell contract, she will apply her knowledge of the central and peripheral endocannabinoid system to a perinatal research line focused on intrauterine growth restriction. This is particularly relevant since some of the objectives of her Sara Borrell contract coincide with and complement the aims of this funding application. To date, she has 19 publications and one book chapter, being first author on 11 of them (more than 50%) and corresponding author on 4. The results have been presented in 35 conference communications, 12 of which were international; Dr. de Ceglia is first author on 17 of them.